Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and more STATIn surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment STATManufacturing problems cited in FDA rejection of ITM’s radiopharma drug Endpoints NewsITM cancer drug spurned by FDA over manufacturing qualms Fierce PharmaITM receives Complete Response Letter for ITM-11 AuntMinnie
